Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Marat Fudim Added: 8 months ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat… View more
Added: 1 month ago Source:  Radcliffe Vascular
The use of paclitaxel-coated devices for infrainguinal endovascular revascularisation does not reduce the rate of major amputation or all-cause mortality in patients with chronic limb-threatening ischaemia (CLTI), according to findings from a large registry-based trial in Sweden.¹ Peripheral artery disease (PAD) is a significant global health issue, and for patients with its most severe form,… View more
Added: 2 months ago Source:  Transcatheter Academy
The use of paclitaxel-coated devices did not reduce the rate of major amputations or death in patients with chronic limb-threatening ischaemia (CLTI) undergoing infrainguinal endovascular revascularisation, according to the results of a large registry-based trial.¹ While drug-coated devices are commonly used in peripheral interventions, their effect on amputation risk has been uncertain.²The… View more
Added: 8 months ago Source:  Radcliffe Cardiology
AUTHOR: David RamseyA multicenter registry study from the European CTO Club has revealed a remarkable 52% reduction (p<0.001) in radiation exposure for percutaneous coronary interventions (PCI) in chronic total occlusion (CTO) cases over 12 years. Despite increasing lesion complexity, improved procedural success and modernization of radiation management strategies have significantly lowered… View more
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 3 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more
Job title: Associate Professor and Senior Consultant
Dr Lund's expertise is in HF big data and registry-based comparative outcomes studies and pragmatic trials. He is active in programs to improve utilisation of existing evidence-based interventions in heart failure with reduced ejection fraction, as well as in novel interventions. Dr Lars Lund is an Editorial Board member ofCardiac Failure Review. View more